|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.30 USD | -2.45% |
|
-0.23% | -11.78% |
| Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
| Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
Executive Committee: NovoCure Limited
| Manager | Positions heldSince | ||
|---|---|---|---|
![Ashley Cordova](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Ashley Cordova 46 year |
| ||
Ingrid Goldberg |
| ||
Michael Puri 56 year |
| ||
Nicolas Leupin 51 year |
| ||
Moshe Giladi |
| ||
Barak Ben Arye 49 year |
| ||
Christoph Brackmann 51 year |
|
Composition of the Board of Directors: NovoCure Limited
| Director | CommitteesSince | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Bill Doyle 62 year |
| ||||||||||
Jeryl Hilleman 68 year |
| ||||||||||
Tony Vernon 70 year |
| ||||||||||
 Timothy Scannell 61 year |
| ||||||||||
Kin Yip Leung 64 year |
| ||||||||||
Martin Madden 65 year |
| ||||||||||
David Hung 68 year |
| ||||||||||
Allyson Ocean 54 year |
| ||||||||||
Kristin Stafford 44 year |
| ||||||||||
Asaf Danziger 57 year |
|
Latest Appointments: NovoCure Limited
Former Officers and Directors: NovoCure Limited
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 16 |
|---|---|
| Female | 6 |
Of which Executive Committee
| Male | 5 |
|---|---|
| Female | 2 |
Of which Directors
| Male | 8 |
|---|---|
| Female | 2 |
ESG
